Bristol-Myers Seeks to Sell Excedrin Line
284786
Bristol-Myers Squibb, the pharmaceutical company, is in talks to sell its Excedrin line of pain relievers for as much as $1 billion.
227401
Bristol-Myers Squibb said yesterday that it would pay $430 million for Adnexus Therapeutics, a privately held biotechnology company whose lead product is a cancer drug in the earliest stages of human trials.
660344
Israel's Teva Pharmaceutical  Industries Ltd. has agreed to buy Pfizer Inc.'s Italian generic  drug marketing company and is hungry for more acquisitions, the  drugmaker said on Tuesday.
352630
Drug maker Pfizer Inc. (PFE.N: Quote, Profile, Research) on Tuesday said it won regulatory clearance to sell its anti-fungus medicine Vfend to treat serious hospital-acquired bloodstream infections.
711535
Pharmacy-benefit manager Express Scripts Inc. launched a $26 billion bid Monday for its larger competitor Caremark Rx Inc., potentially scuttling a competing offer from drug chain CVS/pharmacy.
178534
U.S. pharmaceutical company Bristol-Myers Squibb  has hired three Wall Street banks ahead of a possible offer from France's Sanofi-Aventis , the Financial Times reported on Tuesday.
463698
The French pharmaceutical company has lost a crucial slice of the U.S. market and seen its shares tumble. Talks of an acquisition could be food for thought.
751749
Bristol-Myers Squibb plans to ask US regulators to allow it to sell Pravachol over the counter, in a move that could shake up the growing, lucrative market for cholesterol-reducing drugs.
303420
The Boston Scientific Corporation, the maker of medical devices, said on Thursday that it had agreed to sell its fluid management and venous access businesses for $425 million to the private equity firm Avista Capital Partners.
636655
Pfizer Inc. said on Thursday it is in  talks to acquire a private biotechnology company called  Angiosyn Inc., which is developing a drug for macular  degeneration, the leading cause of blindness in the elderly.
668273
Pfizer Inc. said on Thursday it is in talks to acquire a private biotechnology company called Angiosyn Inc., which is developing a drug for macular degeneration, the leading cause of blindness in the elderly.
411592
It makes sense for the drugmaker to sell millions more shares right now.
745945
GlaxoSmithKline PLC is in talks with the Food and Drug Administration about selling its Fluarix influenza vaccine in the United States this season because of the expected flu vaccine shortage this year.
666433
Drug maker Pfizer Inc. said Tuesday it won regulatory clearance to sell its anti-fungus medicine Vfend to treat serious hospital-acquired bloodstream infections.
506494
Several of the world's top  drugmakers may weigh acquiring Bristol-Myers Squibb Co.   after it fired its chief executive, although suitors seem  unlikely to bid before next summer, analysts said.
538850
Australian Pharmaceutical Industries Ltd., the nation&#39;s biggest drug wholesaler, agreed to buy New Price Retail for A$112.4 million ($78 million) in cash and stock, expanding its store network by two thirds.
43560
A drug wholesaler accused of overcharging for flu vaccine agreed Wednesday to turn over its remaining inventory - a total of five vials - and to no longer buy or sell it.